Abstract
The novel Coronavirus Disease, COVID-19, was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19, a disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), continues to spread worldwide. SARS-CoV-2 is of the Orthocoronavirinae sub-family, which shares genome sequence similarity with two other highly pathogenic members of the group, Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). All three members are thought to have emerged from zoonotic events that have triggered global outbreaks over the last two decades. There is currently no cure, vaccine, or standard treatment protocol for COVID-19. The global pandemic of COVID-19 has had serious consequences with such an alarming rate of morbidity and mortality. Computer-aided drug design (CADD) could help quickly repurpose drugs that have been approved by the FDA and also to identify new antiviral compounds. The CADD can significantly reduce costs and enhance the drug development process by narrowing down potential drug compounds. This chapter comprehends resources and tools available for drug development against the novel coronavirus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Lee PI, Hsueh PR (2020) Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. Elsevier, Amsterdam. https://www.sciencedirect.com/science/article/pii/S1684118220300116/pdf?md5=682eac74614c6814574721240cbafeea&pid=1-s2.0-S1684118220300116-main.pdf. Accessed 12 Sep 2020
Lai C, Shih T, Ko W, Tang H, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Elsevier, Amsterdam. https://www.sciencedirect.com/science/article/pii/S0924857920300674. Accessed 13 Sep 2020
Mungroo M, Khan N, Siddiqui R (2020) Novel coronavirus: current understanding of clinical features, diagnosis, pathogenesis, and treatment options. Pathogens 9:297. https://www.mdpi.com/2076-0817/9/4/297/htm. Accessed 13 Sep 2020
Kumar S (2020) COVID-19: a drug repurposing and biomarker identification by using comprehensive gene-disease associations through protein-protein interaction network analysis. Preprints. https://doi.org/10.20944/preprints202003.0440.v1
Zhang YZ, Holmes EC (2020) A genomic perspective on the origin and emergence of SARS-CoV-2. Cell 181(2):223–227. https://doi.org/10.1016/j.cell.2020.03.035
Sci S, Teng X, Huasheng X (2009) Perspectives of DNA microarray and next-generation DNA sequencing technologies. China Ser C-Life Sci 52(1):7–16. https://doi.org/10.1007/s11427-009-0012-9
Bernasconi A, Cankoglu A, Pinoli P, Ceri S (2020) Empowering virus sequences research through conceptual modeling. BioRxiv. https://doi.org/10.1101/2020.04.29.067637
Drie JH (2007) Computer-aided drug design: the next 20 years. J Comput Aided Mol Des 21:591. https://doi.org/10.1007/s10822-007-9142-y
Huang HJ et al (2010) Current developments of computer-aided drug design. J Taiwan Inst Chem Eng 41:623. https://doi.org/10.1016/j.jtice.2010.03.017
Veselovsky V, Ivanov AS (2003) Strategy of computer-aided drug design. Curr Drug Targets Infect Disord 3:33. https://doi.org/10.2174/1568005033342145
Kapetanovic M (2008) Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chem Biol Interact 171:165. https://doi.org/10.1016/j.cbi.2006.12.006
Swinney DC, Anthony J (2011) How were new medicines discovered? Nat Rev Drug Discov 10(7):507–519. https://doi.org/10.1038/nrd3480
Hassan Baig M et al (2016) Computer aided drug design: success and limitations. Curr Pharm Des 22:572. Accessed 13 Sep 2020
Zumla JF, Chan W, Azhar EI, Hui DSC, Yuen KY (2016) Coronaviruses-drug discovery and therapeutic options. Nat Rev Drug Discov 15(5):327–347. https://doi.org/10.1038/nrd.2015.37
Li G, de Clercq E (2020) Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 19(3):149–150. https://doi.org/10.1038/d41573-020-00016-0
Lurie N, Saville M, Hatchett R, Halton J (2020) Developing covid-19 vaccines at pandemic speed. N Engl J Med 382(21):1969–1973. https://doi.org/10.1056/NEJMp2005630
Morse S, Lalonde T, Xu S, Liu WR (2020) Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. ChemBioChem 21(5):730–738. https://doi.org/10.1002/cbic.202000047
Köser C, Ellington M et al (2012) Routine use of microbial whole genome sequencing in diagnostic and public health microbiology. PLoS Pathog 8(8):e1002824. https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1002824. Accessed 13 Sep 2020
Polonsky A et al (2019) Outbreak analytics: a developing data science for informing the response to emerging pathogens. Philos Trans Roy Soc B Biol Sci 374(1776):20180276. https://doi.org/10.1098/rstb.2018.0276
Köser CU et al (2012) Routine use of microbial whole genome sequencing in diagnostic and public health microbiology. PLoS Pathog 8(8):e1002824. https://doi.org/10.1371/journal.ppat.1002824
Gardy J, Loman N (2018) Towards a genomics-informed, real-time, global pathogen surveillance system. Nat Rev Genet 19:9. https://www.nature.com/articles/nrg.2017.88.pdf?origin=ppub. Accessed 13 Sep 2020
Shu Y, McCauley J (2017) GISAID: global initiative on sharing all influenza data – from vision to reality. Eurosurveillance 22(13):30494. https://doi.org/10.2807/1560-7917.ES.2017.22.13.30494
Pruitt K, Tatusova T, Maglott DR (2005) NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 33:D501. https://academic.oup.com/nar/article-abstract/33/suppl_1/D501/2505241. Accessed 13 Sep 2020
Madeira F, Madhusoodanan N, Lee J, Tivey ARN, Lopez R (2019) Using EMBL-EBI Services via web interface and programmatically via web services. Curr Protoc Bioinformatics 66(1):e74. https://doi.org/10.1002/cpbi.74
COVID-19 Genomics UK (COG-UK) (2020) An integrated national scale SARS-CoV-2 genomic surveillance network. Lancet Microbe 1:e99. https://doi.org/10.1016/s2666-5247(20)30054-9
Zhao W, Song S, Chen M, Zou D et al (2020) The 2019 novel coronavirus resource. Yi Chuan 42:212. https://europepmc.org/article/med/32102777. Accessed 13 Sep 2020
Burley SK, Berman HM, Kleywegt GJ, Markley JL, Nakamura H, Velankar S (2017) Protein Data Bank (PDB): the single global macromolecular structure archive. Methods Mol Biol 1607:627–641
Bolton E, Wang Y, Thiessen P, Bryant S (2008) PubChem: integrated platform of small molecules and biological activities. Annu Rep Comput Chem 4:217. https://www.sciencedirect.com/science/article/pii/S1574140008000121. Accessed 13 Sep 2020
Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: a free tool to discover chemistry for biology. ACS Publ 52(7):1757–1768. https://doi.org/10.1021/ci3001277
Wishart DS (2008) DrugBank and its relevance to pharmacogenomics. Pharmacogenomics 9(8):1155–1162. https://doi.org/10.2217/14622416.9.8.1155
Gaulton A, Hersey A et al (2017) The ChEMBL database in 2017. Nucleic Acids Res 45:D945. https://academic.oup.com/nar/article-abstract/45/D1/D945/2605707. Accessed 13 Sep 2020
Xu X et al (2020) Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 63(3):457–460. https://doi.org/10.1007/s11427-020-1637-5
Ceraolo C, Giorgi FM (2020) Genomic variance of the 2019-nCoV coronavirus. J Med Virol 92(5):522–528. https://doi.org/10.1002/jmv.25700
Korber B, Fischer W, Gnanakaran S, Yoon H et al (2020) Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell 182:812. https://www.sciencedirect.com/science/article/pii/S0092867420308205. Accessed 13 Sep 2020
Okubo K, Sugawara H et al (2006) DDBJ in preparation for overview of research activities behind data submissions. Nucleic Acids Res 34:D6. https://academic.oup.com/nar/article-abstract/34/suppl_1/D6/1133559. Accessed 13 Sep 2020
Geer LY, Marchler-Bauer A et al (2010) The NCBI biosystems database. Nucleic Acids Res 38:D492. https://academic.oup.com/nar/article-abstract/38/suppl_1/D492/3112224. Accessed 13 Sep 2020
McWilliam H, Li W, Uludag M et al (2013) Analysis tool web services from the EMBL-EBI. Nucleic Acids Res 41:W597. https://academic.oup.com/nar/article-abstract/41/W1/W597/1095852. Accessed 13 Sep 2020
Goujon M, McWilliam H et al (2010) A new bioinformatics analysis tools framework at EMBL–EBI. Nucleic Acids Res 38:W695. https://academic.oup.com/nar/article-abstract/38/suppl_2/W695/1097251. Accessed 13 Sep 2020
Pybus O, Rambaut A, et al (2020) Preliminary analysis of SARS-CoV-2 importation & establishment of UK transmission lineages. Accessed 13 Sep 2020
Vénien-Bryan C, Li Z, Vuillard L, Boutin JA (2017) Cryo-electron microscopy and X-ray crystallography: complementary approaches to structural biology and drug discovery 1. Med Sci 73:758–767. https://doi.org/10.1107/S2053230X17003740
Wang HW, Wang JW (2017) How cryo-electron microscopy and X-ray crystallography complement each other. Protein Sci 26(1):32–39. https://doi.org/10.1002/pro.3022
Kim S et al (2016) PubChem substance and compound databases. Nucleic Acids Res 44:D1202. https://doi.org/10.1093/nar/gkv951
Li Q, Cheng T, Wang Y, Bryant S (2010) PubChem as a public resource for drug discovery. Drug Discov Today 15:1052. https://www.sciencedirect.com/science/article/pii/S1359644610007737. Accessed 13 Sep 2020
Cheng T, Li Q, Zhou Z, Wang Y, Bryant SH (2012) Structure-based virtual screening for drug discovery: a problem-centric review. AAPS J 14(1):133–141. https://doi.org/10.1208/s12248-012-9322-0
McInnes C (2007) Virtual screening strategies in drug discovery. Curr Opin Chem Biol 11(5):494. https://www.sciencedirect.com/science/article/pii/S1367593107001172. Accessed 13 Sep 2020
Ferreira L, dos Santos R, Oliva G, Andricopulo A (2015) Molecular docking and structure-based drug design strategies. Molecules 20:13384. https://www.mdpi.com/1420-3049/20/7/13384/htm. Accessed 13 Sep 2020
Mandal S, Moudgil S et al (2009) Rational drug design. Eur J Pharmacol 625:90. https://www.sciencedirect.com/science/article/pii/S0014299909008784. Accessed 13 Sep 2020
Henrich S, Salo-Ahen OMH, Huang B, Rippmann F, Cruciani G, Wade RC (2010) Computational approaches to identifying and characterizing protein binding sites for ligand design. J Mol Recognit 23(2):209–219. https://doi.org/10.1002/jmr.984
Berg JM, Tymoczko JL, Stryer L (2002) Three-dimensional protein structure can be determined by NMR spectroscopy and X-ray crystallography. In: Biochemistry. W H Freeman, New York, NY. https://www.ncbi.nlm.nih.gov/books/NBK22393/. Accessed 13 Sep 2020
Mahajan R, Gupta K (2010) Adaptive design clinical trials: methodology, challenges and prospect. Indian J Pharm 42(4):201–207. https://doi.org/10.4103/0253-7613.68417
Zhang Z (2003) An overview of protein structure prediction: from homology to ab initio. Accessed 13 Sep 2020
Vyas VK, Ukawala RD, Ghate M, Chintha C (2012) Homology modeling a fast tool for drug discovery: current perspectives. Indian J Pharm Sci 74(1):1–17. https://doi.org/10.4103/0250-474X.102537
Kihara D, Chen H, Yang Y (2009) Quality assessment of protein structure models. Curr Protein Pept Sci 10(3):216–228. https://doi.org/10.2174/138920309788452173
David Andersson C, Chen BY, Linusson A (2010) Mapping of ligand-binding cavities in proteins. Proteins 78(6):1408–1422. https://doi.org/10.1002/prot.22655
Ezzat A, Kwoh CK (2012) Comparison of structure-based tools for the prediction of ligand binding site residues in apo-structures. Proc Comput Sci 11:115–126. https://doi.org/10.1016/j.procs.2012.09.013
Kontoyianni M (2017) Docking and virtual screening in drug discovery. Methods Mol Biol 1647:255–266
Pollard TD (2010) MBOC technical perspective: a guide to simple and informative binding assays. Mol Biol Cell 21(23):4061–4067. https://doi.org/10.1091/mbc.E10-08-0683
Bhattacharya D, Cao R, Cheng J (2016) UniCon3D: de novo protein structure prediction using united-residue conformational search via stepwise, probabilistic sampling. Bioinformatics 32(18):2791–2799. https://doi.org/10.1093/bioinformatics/btw316
Acharya C, Coop A, Polli JE, MacKerell AD (2010) Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach. Curr Comput Aid Drug Des 7(1):10–22. https://doi.org/10.2174/157340911793743547
Chevillard F et al (2018) Binding-site compatible fragment growing applied to the design of β2-adrenergic receptor ligands. J Med Chem 61(3):1118–1129. https://doi.org/10.1021/acs.jmedchem.7b01558
Atkovska K, Samsonov SA, Paszkowski-Rogacz M, Pisabarro MT (2014) Multipose binding in molecular docking. Int J Mol Sci 15(2):2622–2645. https://doi.org/10.3390/ijms15022622
Pantsar T, Poso A (2018) Binding affinity via docking: fact and fiction. Molecules 23(8):1. https://doi.org/10.3390/molecules23081899
Lexa KW, Carlson HA (2012) Protein flexibility in docking and surface mapping. Q Rev Biophys 45(3):301–343. https://doi.org/10.1017/S0033583512000066
Unger R, Moult J (1993) Genetic algorithms for protein folding simulations. J Mol Biol 231(1):75–81. https://doi.org/10.1006/jmbi.1993.1258
Mackay DHJ, Cross AJ, Hagler AT (1989) The role of energy minimization in simulation strategies of biomolecular systems. In: Prediction of protein structure and the principles of protein conformation. Springer, Boston, MA, pp 317–358
Qing X et al (2014) Pharmacophore modeling: advances, limitations, and current utility in drug discovery. J Recept Lig Chann Res 7:81. https://doi.org/10.2147/JRLCR.S46843
Chandrasekaran B, Agrawal N, Kaushik S (2018) Pharmacophore development. In: Encyclopedia of bioinformatics and computational biology: ABC of bioinformatics, vol 1–3. Elsevier, Amsterdam, pp 677–687
Chen B-S, Li C-W (2017) Big drug design mechanisms via systems biology and big database mining. In: Big mechanisms in systems biology. Elsevier, Amsterdam, pp 737–845
Hao GF et al (2016) ACFIS: a web server for fragment-based drug discovery. Nucleic Acids Res 44(W1):W550–W556. https://doi.org/10.1093/nar/gkw393
Stourac J et al (2019) Caver Web 1.0: identification of tunnels and channels in proteins and analysis of ligand transport. Nucleic Acids Res 47(W1):W414–W422. https://doi.org/10.1093/nar/gkz378
Irwin JJ et al (2009) Automated docking screens: a feasibility study. J Med Chem 52(18):5712–5720. https://doi.org/10.1021/jm9006966
London N et al (2014) Covalent docking of large libraries for the discovery of chemical probes. Nat Chem Biol 10(12):1066–1072. https://doi.org/10.1038/nchembio.1666
Santos KB, Guedes IA, Karl ALM, Dardenne LE (2020) Highly flexible ligand docking: benchmarking of the DockThor program on the LEADS-PEP protein-peptide data set. J Chem Inf Model 60(2):667–683. https://doi.org/10.1021/acs.jcim.9b00905
Pires DEV et al (2020) EasyVS: a user-friendly web-based tool for molecule library selection and structure-based virtual screening. Bioinformatics 36(14):4200–4202. https://doi.org/10.1093/bioinformatics/btaa480
Douguet D (2010) e-LEA3D: a computational-aided drug design web server. Nucleic Acids Res 38(Suppl 2):W615. https://doi.org/10.1093/nar/gkq322
Tao Y, Huang Y, Shinohara M, Caylor L, Pashikanti S, Xu D (2019) EzCADD: a rapid 2D/3D visualization-enabled web modeling environment for democratizing computer-aided drug design. J Chem Inf Model 59(1):18–24. https://doi.org/10.1021/acs.jcim.8b00633
Tsai Y, Chang KW, Chen CYC (2011) IScreen: world’s first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan. J Comput Aided Mol Des 25(6):525–531. https://doi.org/10.1007/s10822-011-9438-9
Labbé M et al (2015) MTiOpenScreen: a web server for structure-based virtual screening. Nucleic Acids Res 43(W1):W448–W454. https://doi.org/10.1093/nar/gkv306
Sunseri J, Koes DR (2016) Pharmit: interactive exploration of chemical space. Nucleic Acids Res 44(W1):W442–W448. https://doi.org/10.1093/nar/gkw287
Gheyouche E et al (2019) Docknmine, a web portal to assemble and analyse virtual and experimental interaction data. Int J Mol Sci 20(20):5062. https://doi.org/10.3390/ijms20205062
Wang J, Dokholyan NV (2019) MedusaDock 2.0: efficient and accurate protein-ligand docking with constraints. J Chem Inf Model 59(6):2509–2515. https://doi.org/10.1021/acs.jcim.8b00905
Grosdidier A, Zoete V, Michielin O (2011) SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res 39(Suppl 2):W270. https://doi.org/10.1093/nar/gkr366
Neves J, Braga RC, Melo-Filho CC, Moreira-Filho JT, Muratov EN, Andrade CH (2018) QSAR-based virtual screening: advances and applications in drug discovery. Front Pharmacol 9:1275. https://doi.org/10.3389/fphar.2018.01275
Zhu H (2013) From QSAR to QSIIR: searching for enhanced computational toxicology models. Methods Mol Biol 930:53–65. https://doi.org/10.1007/978-1-62703-059-5_3
Hong H, Fang H, Xie Q, Perkins R, Sheehan DM, Tong W (2003) Comparative molecular field analysis (CoMFA) model using a large diverse set of natural, synthetic and environmental chemicals for binding to the androgen receptor. SAR QSAR Environ Res 14(5–6):373–388. https://doi.org/10.1080/10629360310001623962
Maggiora G, Vogt M, Stumpfe D, Bajorath J (2014) Molecular similarity in medicinal chemistry. J Med Chem 57(8):3186–3204. https://doi.org/10.1021/jm401411z
Yang Y (2010) Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov Today 15(11–12):444–450. https://doi.org/10.1016/j.drudis.2010.03.013
Gurrath M, Müller G, Höltje H-D (2005) Pseudoreceptor modelling in drug design: applications of Yak and PrGen. In: 3D QSAR in drug design. Kluwer Academic Publishers, New York, NY, pp 135–157
Tanrikulu Y, Schneider G (2008) Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening. Nat Rev Drug Discov 7(8):667–677. https://doi.org/10.1038/nrd2615
Bajorath J (2017) Computational scaffold hopping: cornerstone for the future of drug design? Future Med Chem 9(7):629–631. https://doi.org/10.4155/fmc-2017-0043
Sun H, Tawa G, Wallqvist A (2012) Classification of scaffold-hopping approaches. Drug Discov Today 17(7–8):310–324. https://doi.org/10.1016/j.drudis.2011.10.024
Colledge M, Wallace BA (2017) AnglerFish: a webserver for defining the geometry of α-helices in membrane proteins. Bioinformatics 33(8):1233–1234. https://doi.org/10.1093/bioinformatics/btw781
Kringelum J, Kjaerulff SK, Brunak S, Lund O, Oprea TI, Taboureau O (2016) ChemProt-3.0: a global chemical biology diseases mapping. Database 2016:bav123. https://doi.org/10.1093/database/bav123
Hamad S, Adornetto G, Naveja JJ, Chavan Ravindranath A, Raffler J, Campillos M (2019) HitPickV2: a web server to predict targets of chemical compounds. Bioinformatics 35(7):1239–1240. https://doi.org/10.1093/bioinformatics/bty759
Peón A et al (2019) MolTarPred: a web tool for comprehensive target prediction with reliability estimation. Chem Biol Drug Des 94(1):1390–1401. https://doi.org/10.1111/cbdd.13516
Alberga D, Trisciuzzi D, Montaruli M, Leonetti F, Mangiatordi GF, Nicolotti O (2019) A new approach for drug target and bioactivity prediction: the multifingerprint similarity search algorithm (MuSSeL). J Chem Inf Model 59(1):586–596. https://doi.org/10.1021/acs.jcim.8b00698
Awale M, Reymond JL (2019) Polypharmacology browser PPB2: target prediction combining nearest neighbors with machine learning. J Chem Inf Model 59(1):10–17. https://doi.org/10.1021/acs.jcim.8b00524
Lee K, Lee M, Kim D (2017) Utilizing random Forest QSAR models with optimized parameters for target identification and its application to target-fishing server. BMC Bioinformatics 18:567. https://doi.org/10.1186/s12859-017-1960-x
Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK (2007) Relating protein pharmacology by ligand chemistry. Nat Biotechnol 25(2):197–206. https://doi.org/10.1038/nbt1284
Nickel J et al (2014) SuperPred: update on drug classification and target prediction. Nucleic Acids Res 42(W1):W26. https://doi.org/10.1093/nar/gku477
Gfeller D, Grosdidier A, Wirth M, Daina A, Michielin O, Zoete V (2014) SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res 42(W1):W32. https://doi.org/10.1093/nar/gku293
Yao ZJ et al (2016) TargetNet: a web service for predicting potential drug–target interaction profiling via multi-target SAR models. J Comput Aided Mol Des 30(5):413–424. https://doi.org/10.1007/s10822-016-9915-2
Gonzalez-Paz L et al (2020) Theoretical molecular docking study of the structural disruption of the viral 3CL-protease of COVID19 induced by binding of capsaicin, piperine and curcumin Part 1: a comparative study with chloroquine and hydrochloroquine two antimalaric drugs. Res Sq. https://doi.org/10.21203/rs.3.rs-21206/v1
Baruah C, Devi P, Sharma DK (2020) Sequence analysis and structure prediction of SARS-CoV-2 accessory proteins 9b and ORF14: evolutionary analysis indicates close relatedness to bat coronavirus. ChemRxiv. https://doi.org/10.26434/CHEMRXIV.12424958.V1
Mouroug Anand N et al (2020) A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing. ChemRxiv. https://doi.org/10.26434/CHEMRXIV.12430919.V1
Roomi MS, Daanial Khan Y (2020) Potential compounds for the inhibition of TMPRSS2. ChemRxiv. https://doi.org/10.26434/CHEMRXIV.12727787.V1
Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N (2020) Computational drug discovery and repurposing for the treatment of COVID-19: a systematic review. SSRN Electron J. https://doi.org/10.2139/ssrn.3583748
Kumar S (2020) Drug and vaccine design against novel coronavirus (2019-nCoV) spike protein through computational approach. Preprints. https://www.preprints.org/manuscript/202002.0071/v1. Accessed 13 Sep 2020
Gentile D, Patamia V, Scala A, Sciortino MT, Piperno A, Rescifina A (2020) Putative inhibitors of SARS-CoV-2 main protease from a library of marine natural products: a virtual screening and molecular modeling study. Mar Drugs 18(4):225. https://doi.org/10.3390/md18040225
Sayed M et al (2020) Microbial natural products as potential inhibitors of SARS-CoV-2 main protease (Mpro). Microorganisms 8(7):1–17. https://doi.org/10.3390/microorganisms8070970
Das S, Sarmah S, Lyndem S, Singha Roy A (2020) An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. J Biomol Struct Dyn:1–11. https://doi.org/10.1080/07391102.2020.1763201
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kumar, S. (2021). Online Resource and Tools for the Development of Drugs Against Novel Coronavirus. In: Roy, K. (eds) In Silico Modeling of Drugs Against Coronaviruses. Methods in Pharmacology and Toxicology. Humana, New York, NY. https://doi.org/10.1007/7653_2020_53
Download citation
DOI: https://doi.org/10.1007/7653_2020_53
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1365-8
Online ISBN: 978-1-0716-1366-5
eBook Packages: Springer Protocols